Accelerating Data-Driven Drug Development

Wednesday, September 18, 2019 - 1:00 PM to 2:30 PM
Information Technology and Innovation Foundation
1101 K Street NW, Suite 610A
Washington, DC 20005

From screening chemical compounds to optimizing clinical trials to improving post-market surveillance of drugs, the increased use of data and better analytical tools such as artificial intelligence hold the potential to transform drug development, leading to new treatments, improved patient outcomes, and lower costs. However, several obstacles, particularly a lack of access to data, prevent the United States from achieving the full promise of data-driven drug development. Whether policymakers act to overcome these challenges will have a significant impact on both the well-being of Americans and the competitiveness of the United States. 

ITIF's Center for Data Innovation released a new report exploring opportunities to accelerate data-driven innovation in drug development and hosted a panel discussion about the ways data can make drug development faster, more efficient, and lead to new cures.

Follow the discussion on Twitter with the hashtag #datainnovation.

09/18/2019 13:0009/18/2019 14:30America/New_YorkITIF Event: Accelerating Data-Driven Drug DevelopmentInformation Technology and Innovation Foundation , 1101 K Street NW, Suite 610A, Washington, DC 20005More information:
Joshua New
Former Senior Policy Analyst
ITIF’s Center for Data Innovation
Christopher Austin
National Center for Advancing Translational Sciences, NIH
Bradford Casey
Associate Director of Research Programs
The Michael J. Fox Foundation
Subha Madhavan
Chief Data Scientist, Georgetown University Medical Center and Director, Biomedical Informatics